Immunotherapy Treatments Bring Hope To Cancer Patients
“Cancer has the phenomenal ability to cloak itself and hide from the immune system so it can grow and spread. Now we have, for various cancers, the ability to stimulate the immune system to attack cancer when chemotherapy drugs might not even work,” shares Dr. Geils. “The major progress we’ve seen is the benefit to patients due to the reduction of negative side effects when employing immunotherapy treatment where appropriate. We fully expect more advances to come.” In 2015, research showed the drugs ipilimumab and nivolumab stopped melanoma from advancing for nearly a year in 58% of cancer cases. Many other studies showing the promise of immunotherapy have been published since that time. As of 2020, 800 combination immunotherapy trials were going on in different indications. In addition to immunotherapy treatment, Charleston Oncology offers a myriad of clinical trials to patients, including immunotherapy trials.
Send UsA Message
I am currently undergoing treatment for breast cancer at Roper St. Francis Hospital and would like to acknowledge two physicians who truly embody your mission of “healing with compassion, faith and excellence”.
Please join Charleston Oncology and the American Association for Cancer Research (AACR) in support of National Survivor Month, celebrating those who have fought the disease and those currently in treatment.
June is National Cancer Survivor Month and throughout the month we are honoring our brave patients and sharing their inspirational stories.
May is Skin Cancer Awareness Month. Melanoma is a type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control. Watch the video to learn more about melanoma from Charleston Oncology’s Dr. Charles S. Holladay.
March is Colorectal Cancer Awareness Month. This month, Charleston Oncology recognizes the importance of spreading awareness surrounding the disease.
Dr. Shelly Shand shares important tips for diagnosing breast cancer early and the latest advancements in breast cancer.